t-Butyloxycarbonyl: An ordinary but promising group for protecting peptides from deiodination

Applied Radiation and Isotopes

Volumn 64, Issue 6, 2006, Pages 645-650

  Sun, Xin ^a   Chu, Taiwei ^a   Liu, Xinqi ^a   Wang, Xiangyun ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Biodistribution; CNGRC; Deiodination; Radioiodination; t BOC

Indexed keywords

PROTEINS; RADIOACTIVITY; RADIOISOTOPES; SYNTHESIS (CHEMICAL);

BIODISTRIBUTION; CNGRC; DEIODINATION; RADIOIODINATION;

AMINO ACIDS;

CARBONYL DERIVATIVE; CYCLOPEPTIDE; IODINE 125; IODINE 131; PEPTIDE YG5; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DEIODINATION; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RADIOACTIVITY; RADIOIODINATION; STOMACH; THYROID GLAND;

ANIMALS; FORMIC ACID ESTERS; HUMANS; IODINE RADIOISOTOPES; MICE; OLIGOPEPTIDES; RADIOPHARMACEUTICALS; STOMACH; THYROID GLAND; TISSUE DISTRIBUTION;

EID: 33646010944     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2005.12.019     Document Type: Article

References (18)

1. Bakker W.H., Krenning E.P., Breeman W.A., Kooij P.P.M., Reubi J.C., Koper J.W., de Jong M., Lameris J.S., Visser T.J., and Lamberts S.W. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J. Nucl. Med. 32 (1991) 1184-1189
2. Bakker W.H., Krenning E.P., Breeman W.A., Koper J.W., Kooij P.P., Reubi J.C., Klijn J.G., Visser T.J., Docter R., and Lamberts S.W. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals. J. Nucl. Med. 31 (1990) 1501-1509
3. Foulon C.F., Reist C.J., Bigner D.D., and Zalutsky M.R. Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody. Cancer Res. 60 (2000) 4453-4460
4. Geissler F., Anderson S.K., Venkatesan P., and Press O. Intracellular catabolism of radiolabeled anti-mu antibodies by malignant B-cells. Cancer Res. 52 (1992) 2907-2915
5. Hart S.L., Knight A.M., Harbottle R.P., Mistry A., Hunger H.D., Cutler D.F., Williamson R., and Coutelle C. Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J. Biol. Chem. 269 (1994) 12468-12474
6. Huang W., and Chen C. The protection of amino group. In: Wu T. (Ed). Peptide Synthesis (1985), Science Press, Beijing 13-44
7. Iuchi K., Nitta M., Ito K., Molimoto Y., and Tsukamoto G. Synthesis and analgesic activity of cholecystokinin-heptapeptide analogs with N-terminal substitution. Chem. Pharm. Bull. 36 (1988) 959-965
8. Josefsson M., Grunditz T., Ohlsson T., and Ekblad A. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide. Acta. Physiol. Scand. 175 (2002) 129-137
9. Köhrle J. Local activation and inactivation of thyroid hormones: the deiodinase family. Mol. Cell Endocrinol. 151 (1999) 103-119
10. Krummeich C., Holschbach M., and Stocklin G. Direct n.c.a. electrophilic radioiodination of tyrosine analogues; their in vivo stability and brain-uptake in mice. Appl. Radiat. Isot. 45 (1994) 929-935
11. Larson S.M., and Carrasquillo J.A. Advantages of radioiodine over radioindium labeled monoclonal antibodies for imaging solid tumors. Nucl. Med. Biol. 5 (1988) 231-234
12. Pasqualini R., Koivunen E., Kain R., Lahdenranta J., Sakamoto M., Stryhn A., Ashmun R.A., Shapiro L.H., Arap W., and Ruoslahti E. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60 (2000) 722-727
13. Pradeep K.G., Kevin L.A., Philip C.W., and Michael R.Z. Enhanced binding and inertness to dehalogenation of α-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate. Bioconjugate Chem. 7 (1996) 233-239
14. Reist C.J., Garg P.K., Alston K.L., Bigner D.D., and Zalutsky M.R. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate. Cancer Res. 56 (1996) 4970-4977
15. 131I]SIPMB), a negatively charged substituent bearing acylation agent. Nucl. Med. Biol. 31 (2004) 909-919
16. Wang S., Lin H., and Zhou Q. The synthesis of labeled organic compound. In: Wang A., and Ma S. (Eds). Nuclear Medicine and Nuclear Biology: Fundamental and Application (1985), Science Press, Beijing 319-362
17. Wikstrand C.J., Hale L.P., Batra S.K., Hill M.L., Humphrey P.A., Kurpad S.N., McLendon R.E., Moscatello D., Pegram C.N., Reist C.J., Traweek S.T., Wong A.J., Zalutsky M.R., and Bigner D.D. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lungcarcinomas and malignant gliomas. Cancer Res. 55 (1995) 140-3148
18. Zalutsky M.R., and Narula A.S. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl) benzoate intermediate. Cancer Res. 48 (1988) 1446-1450